Fort Washington, PA, United States of America

Alain B Schreiber


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alain B Schreiber

Introduction

Alain B Schreiber, an accomplished inventor based in Fort Washington, PA, has made significant strides in the field of pharmaceuticals. With a portfolio of three patents, his work primarily focuses on enhancing oxygen availability in mammalian tissues, showcasing his dedication to improving medical treatments.

Latest Patents

Schreiber's latest patents revolve around the treatment of conditions that require enhanced oxygen availability. He has disclosed pharmaceutical compositions containing naphthoic acid derivatives and developed methods for their use, aiming to optimize oxygen delivery to mammalian tissues. This innovative approach could hold immense potential for various medical applications.

Career Highlights

Throughout his career, Alain B Schreiber has worked with notable organizations, including Rorer Pharmaceutical Corporation and Rhone-Poulenc Rorer Pharmaceuticals Inc. His experiences in these companies have undoubtedly contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Schreiber has collaborated with esteemed colleagues such as John T Suh and Charles E Pendley II. These partnerships have allowed for the exchange of ideas and knowledge, further enhancing the quality and impact of his inventions.

Conclusion

With a keen focus on advancing medical treatments through innovative pharmaceutical solutions, Alain B Schreiber continues to be a valuable asset to the field of medicine. His contributions not only reflect his dedication as an inventor but also his commitment to improving the quality of life for patients facing various health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…